Surgery for Recurrent Intrahepatic Cholangiocarcinoma


The investigators retrospectively reviewed the participants suffering from recurrent intrahepatic cholangiocarcinoma after curative resection and aimed to explore the predictive factors for recurrence and clarify the potential benefit of repeat hepatectomy or/with metastasectomy.

Full Title of Study: “Surgery for Recurrent Intrahepatic Cholangiocarcinoma: a Promise or an Excess?”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: October 1, 2018


  • Procedure: hepatectomy
    • Hepatectomy for patients with recurrent intrahepatic cholanigocarcinoma

Clinical Trial Outcome Measures

Primary Measures

  • Survival
    • Time Frame: 1977~2014
    • Including overall survival and disease free survival

Participating in This Clinical Trial

Inclusion Criteria

  • R0 resection for intrahepatic cholangiocarcinoma at initial diagnosis.

Exclusion Criteria

  • (1)Patient with R1 or R2 resection
  • (2)Distant metastasis noted when laparotomy
  • (3)Surgical mortality

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 75 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Chang Gung Memorial Hospital
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.